Chunli Wu

机构：Shandong University of Traditional Chinese Medicine, Zhengzhou University, STCube (United States), Zhengzhou University of Science and Technology, Ningbo No. 2 Hospital, Shenzhen Center for Disease Control and Prevention, The Affiliated Yongchuan Hospital of Chongqing Medical University, Ningbo No.6 Hospital, Chongqing Medical University · ORCID：0000-0003-1809-6752

发表论文 112 篇 · 总被引 2390 次 · h-index 29

代表论文

• Cancer-associated fibroblasts: tumor defenders in radiation therapy (2023 · Cell Death and Disease · 被引 50)
• The emerging role of exosomes in radiotherapy (2022 · Cell Communication and Signaling · 被引 43)
• Classification of five SARS-CoV-2 serotypes based on RBD antigenicities (2023 · 中国科学通报：英文版 · 被引 38)
• The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2 (2024 · The Lancet Microbe · 被引 24)
• Pyrazole: An Important Core in Many Marketed and Clinical Drugs (2022 · Russian Journal of Bioorganic Chemistry · 被引 17)
• A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients (2024 · Clinical and Translational Medicine · 被引 15)